Castle biosciences reports second quarter 2022 results

Friendswood, texas--(business wire)--castle biosciences, inc. (nasdaq: cstl), a company improving health through innovative tests that guide patient care, today announced its financial results for the second quarter and six months ended june 30, 2022. “in the second quarter, we saw strong execution across the castle team, which produced another quarter of record test report volume,” said derek maetzold, president and chief executive officer of castle biosciences. “in our core dermatology busine
CSTL Ratings Summary
CSTL Quant Ranking